Yutaka Hanazono

3.8k total citations
113 papers, 3.1k citations indexed

About

Yutaka Hanazono is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Yutaka Hanazono has authored 113 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 53 papers in Genetics and 28 papers in Oncology. Recurrent topics in Yutaka Hanazono's work include Virus-based gene therapy research (46 papers), CRISPR and Genetic Engineering (31 papers) and Pluripotent Stem Cells Research (26 papers). Yutaka Hanazono is often cited by papers focused on Virus-based gene therapy research (46 papers), CRISPR and Genetic Engineering (31 papers) and Pluripotent Stem Cells Research (26 papers). Yutaka Hanazono collaborates with scholars based in Japan, United States and France. Yutaka Hanazono's co-authors include Keiya Ozawa, Cynthia E. Dunbar, Hiroaki Mizukami, Hisamaru Hirai, Akihiro Kume, Takashi Okada, Shin‐ichi Muramatsu, Stephanie Sellers, Ko Sasaki and Robert E. Donahue and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Yutaka Hanazono

107 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaka Hanazono Japan 30 1.9k 1.0k 660 507 493 113 3.1k
Gerhard Bauer United States 29 2.7k 1.4× 1.2k 1.2× 563 0.9× 437 0.9× 680 1.4× 67 4.1k
Akihiro Kume Japan 34 2.2k 1.1× 1.5k 1.4× 618 0.9× 844 1.7× 466 0.9× 135 4.1k
Katsuya Kominami Japan 20 2.0k 1.1× 776 0.8× 361 0.5× 453 0.9× 517 1.0× 31 3.7k
Ernst Pöschl Germany 32 2.0k 1.0× 575 0.6× 307 0.5× 529 1.0× 219 0.4× 66 3.8k
Michael McGrogan United States 31 1.9k 1.0× 582 0.6× 374 0.6× 652 1.3× 993 2.0× 49 3.8k
Derek A. Persons United States 37 2.9k 1.5× 1.8k 1.8× 754 1.1× 668 1.3× 1.1k 2.3× 74 4.7k
Ya‐Wen Chiang United States 26 2.6k 1.3× 2.6k 2.6× 1.3k 2.0× 544 1.1× 257 0.5× 42 4.5k
Martin A. Eglitis United States 21 1.5k 0.8× 1.0k 1.0× 258 0.4× 270 0.5× 629 1.3× 33 2.6k
Lucio H. Castilla United States 23 2.2k 1.2× 651 0.6× 317 0.5× 383 0.8× 790 1.6× 46 3.2k
Hiroh Saji Japan 28 1.5k 0.8× 437 0.4× 339 0.5× 1.1k 2.2× 264 0.5× 91 3.7k

Countries citing papers authored by Yutaka Hanazono

Since Specialization
Citations

This map shows the geographic impact of Yutaka Hanazono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Hanazono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Hanazono more than expected).

Fields of papers citing papers by Yutaka Hanazono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Hanazono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Hanazono. The network helps show where Yutaka Hanazono may publish in the future.

Co-authorship network of co-authors of Yutaka Hanazono

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Hanazono. A scholar is included among the top collaborators of Yutaka Hanazono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Hanazono. Yutaka Hanazono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hara, Hiromasa, et al.. (2023). Nonviral Ex Vivo Genome Editing in Mouse Bona Fide Hematopoietic Stem Cells with CRISPR/Cas9. Methods in molecular biology. 2637. 213–221.
2.
Chanthra, Nawin, Tatsuya Anzai, Keiichiro Koiwai, et al.. (2021). Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.. Journal of Visualized Experiments.
3.
Anzai, Tatsuya, Hiromasa Hara, Nawin Chanthra, et al.. (2021). Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9. Methods in molecular biology. 2320. 247–259. 1 indexed citations
4.
Chanthra, Nawin, Tomoyuki Abe, Matthew Miyamoto, et al.. (2020). A Novel Fluorescent Reporter System Identifies Laminin-511/521 as Potent Regulators of Cardiomyocyte Maturation. Scientific Reports. 10(1). 4249–4249. 20 indexed citations
5.
Ohmori, Tsukasa, Yasumitsu Nagao, Hiroaki Mizukami, et al.. (2017). CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice. Scientific Reports. 7(1). 4159–4159. 109 indexed citations
6.
Abe, Tomoyuki, Yoshikazu Matsuoka, Yoshikazu Nagao, Yoshiaki Sonoda, & Yutaka Hanazono. (2017). CD34-negative hematopoietic stem cells show distinct expression profiles of homing molecules that limit engraftment in mice and sheep. International Journal of Hematology. 106(5). 631–637. 9 indexed citations
7.
Abe, Tomoyuki, Shigeo Masuda, Yujiro Tanaka, et al.. (2012). Maternal administration of busulfan before in utero transplantation of human hematopoietic stem cells enhances engraftments in sheep. Experimental Hematology. 40(6). 436–444. 14 indexed citations
8.
Masuda, Shigeo, Takashi Yokoo, N. Sugimoto, et al.. (2012). A Simplified in Vitro Teratoma Assay for Pluripotent Stem Cells Injected into Rodent Fetal Organs. PubMed. 3(1-3). 103–112. 10 indexed citations
9.
Nagao, Yoshikazu, Tomoyuki Abe, Hideaki Hasegawa, et al.. (2009). Improved Efficacy and Safety of In Utero Cell Transplantation in Sheep Using an Ultrasound-Guided Method. Cloning and Stem Cells. 11(2). 281–285. 12 indexed citations
10.
Masuda, Shigeo, Keiki Kumano, Takahiro Suzuki, et al.. (2009). Dual antitumor mechanisms of Notch signaling inhibitor in a T‐cell acute lymphoblastic leukemia xenograft model. Cancer Science. 100(12). 2444–2450. 22 indexed citations
11.
Tanaka, Yujiro, Shinichiro Nakamura, Hiroaki Shibata, et al.. (2008). Sustained Macroscopic Engraftment of Cynomolgus Embryonic Stem Cells In Xenogeneic Large Animals After In Utero Transplantation. Stem Cells and Development. 17(2). 367–382. 6 indexed citations
12.
Kishi, Yukiko, Makoto Inoue, Yujiro Tanaka, et al.. (2008). Knockout Serum Replacement (KSR) Has a Suppressive Effect on Sendai Virus-Mediated Transduction of Cynomolgus ES Cells. Cloning and Stem Cells. 10(3). 307–312. 2 indexed citations
13.
Sasaki, Katsutomo, Makoto Inoue, Hiroaki Shibata, et al.. (2004). Efficient and stable Sendai virus-mediated gene transfer into primate embryonic stem cells with pluripotency preserved. Gene Therapy. 12(3). 203–210. 18 indexed citations
14.
Nomoto, Tatsuya, Takashi Okada, Kuniko Shimazaki, et al.. (2003). Distinct patterns of gene transfer to gerbil hippocampus with recombinant adeno-associated virus type 2 and 5. Neuroscience Letters. 340(2). 153–157. 18 indexed citations
15.
Mizukami, Hiroaki, Kazufumi Honda, Takashi Okada, et al.. (2003). Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing Arginine–Vasopressin in brattleboro rats. Molecular Therapy. 8(6). 895–902. 22 indexed citations
16.
Muramatsu, Shin‐ichi, Lijun Wang, Kunihiko Ikeguchi, et al.. (2003). Gene Therapy with Virus Vectors for specific Disease of the Nervous System. International review of neurobiology. 55. 205–222. 3 indexed citations
17.
Asano, Takayuki, Yutaka Hanazono, Yasuji Ueda, et al.. (2002). Highly Efficient Gene Transfer into Primate Embryonic Stem Cells with a Simian Lentivirus Vector. Molecular Therapy. 6(2). 162–168. 34 indexed citations
18.
Hanazono, Yutaka, Kevin Brown, & Cynthia E. Dunbar. (2000). Primary T Lymphocytes as Targets for Gene Therapy. Journal of Hematotherapy & Stem Cell Research. 9(5). 611–620. 13 indexed citations
19.
Yu, Jianzhong, Toshihiro Soma, Yutaka Hanazono, & Cynthia E. Dunbar. (1998). Abrogation of TGF-β activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency. Gene Therapy. 5(9). 1265–1271. 15 indexed citations
20.
Tisdale, John F., Yutaka Hanazono, Stephanie Sellers, et al.. (1998). Ex Vivo Expansion of Genetically Marked Rhesus Peripheral Blood Progenitor Cells Results in Diminished Long-Term Repopulating Ability. Blood. 92(4). 1131–1141. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerhard Bauer Breakdown of academic impact, for papers by Akihiro Kume Breakdown of academic impact, for papers by Katsuya Kominami Breakdown of academic impact, for papers by Ernst Pöschl Breakdown of academic impact, for papers by Michael McGrogan Breakdown of academic impact, for papers by Derek A. Persons Breakdown of academic impact, for papers by Ya‐Wen Chiang Breakdown of academic impact, for papers by Martin A. Eglitis Breakdown of academic impact, for papers by Lucio H. Castilla Breakdown of academic impact, for papers by Hiroh Saji
Rankless by CCL
2026